Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 5/20 | 0.69 |
| ▸ | NPY2R | P49146 | 8/20 | 0.68 |
| ▸ | NPY4R | P50391 | 8/20 | 0.68 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.68 |
| ▸ | NPY1R | P25929 | 6/20 | 0.68 |
| ▸ | RAMP1 | O60894 | 1/20 | 0.66 |
| ▸ | RAMP2 | O60895 | 1/20 | 0.66 |
| ▸ | RAMP3 | O60896 | 1/20 | 0.66 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.66 |
| ▸ | TFPI | P10646 | 2/20 | 0.64 |
| ▸ | KDM1A | O60341 | 1/20 | 0.63 |
| ▸ | CCKBR | P32239 | 2/20 | 0.63 |
| ▸ | GLP1R | P43220 | 2/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29868686 | 0.95 | NPY2R (0.68) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL29496288 | 0.92 | NPY2R (0.74) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL31744322 | 0.91 | CALCR (0.77) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL13248707 | 0.91 | NPY2R (0.80) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL31464902 | 0.90 | CALCR (0.69) | CALCRRAMP1RAMP2RAMP3CALCRL | |
| SCHEMBL31464899 | 0.90 | CALCR (0.69) | CALCRRAMP1RAMP2RAMP3CALCRL | |
| SCHEMBL30001479 | 0.90 | CALCR (0.80) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30001037 | 0.90 | CALCR (0.78) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30422726 | 0.90 | CALCR (0.71) | CALCRRAMP1RAMP2RAMP3CALCRL | |
| SCHEMBL30495769 | 0.90 | MAPK8 (0.69) | CALCRNPY2RNPY4RNPY5RNPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3720872-B1 | ANALOGUES OF PYY | IP2IPO INNOVATIONS LTD (GB) | 2026-03-25 | — | — | EP | claimed |
| CN-111727198-B | Pyy analogues | IP2IPO创新有限公司 | 2024-07-09 | — | — | CN | claimed |
| US-12617830-B2 | Analogues of PYY | IP2IPO INNOVATIONS LIMITED (GB) | 2026-05-05 | — | — | US | disclosed |
| EP-3720872-B1 | ANALOGUES OF PYY | IP2IPO INNOVATIONS LTD (GB) | 2026-03-25 | — | — | EP | disclosed |
| US-12060402-B2 | Analogues of PYY | IP2IPO INNOVATIONS LIMITED (GB) | 2024-08-13 | — | — | US | disclosed |
| CN-111727198-B | Pyy analogues | IP2IPO创新有限公司 | 2024-07-09 | — | — | CN | disclosed |
| US-20240166709-A1 | ANALOGUES OF PYY | IP2IPO INNOVATIONS LIMITED (GB) | 2024-05-23 | — | — | US | disclosed |
| US-20230126347-A1 | ANALOGUES OF PYY | IP2IPO INNOVATIONS LIMITED (GB) | 2023-04-27 | — | — | US | disclosed |
| US-11421012-B2 | Analogues of PYY | IP2IPO INNOVATIONS LIMITED (GB) | 2022-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12617830-B2 | Analogues of PYY | GLP1R, INSR, GIPR | CALCR 1972/4885NPY2R 31/4885NPY4R 22/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.